HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child.

Abstract
The X-linked hyper-IgM syndrome (XHIGM) is the most common form of HIGM. Patients are clinically diagnosed on the basis of recurrent sinopulmonary infections, accompanied with low levels of IgG and IgA, normal to elevated levels of IgM, and the presence of peripheral B cells. Here, we have reported a novel deletion of four nucleotides in CD40LG exon 3, c.375_378delCAAA, which led to a frameshift mutation with a premature stop codon, p.Asn101*126. The deletion resulted in a truncated protein, in which majority of the extracellular domain was lost. However, detection of surface CD40L was still possible as the intracellular, transmembrane, and part of the extracellular domains were not affected. This indicated that this mutation did not affect protein stability and that immunodetection of CD40L expression is not enough for the diagnosis of XHIGM. Our study strongly suggests that genetic diagnosis for XHIGM should always be performed when clinical data support this diagnosis and CD40L protein is present.
AuthorsGabriela López-Herrera, José Luis Maravillas-Montero, Alexander Vargas-Hernández, Laura Berrón-Ruíz, Emmanuel Ramírez-Sánchez, Marco Antonio Yamazaki-Nakashimada, Francisco Javier Espinosa-Rosales, Leopoldo Santos-Argumedo
JournalImmunologic research (Immunol Res) Vol. 62 Issue 1 Pg. 89-94 (May 2015) ISSN: 1559-0755 [Electronic] United States
PMID25752457 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CD40 Ligand
Topics
  • Animals
  • Base Sequence
  • CD40 Ligand (genetics, immunology, metabolism)
  • CHO Cells
  • Cricetulus
  • Frameshift Mutation
  • Humans
  • Hyper-IgM Immunodeficiency Syndrome, Type 1 (metabolism)
  • Infant
  • Leukocytes, Mononuclear
  • Sequence Deletion
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: